Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. Apollo Vue $100
2. SeeKIN
3. ApolloVueR B100
Founded Year
2015
Unified Business No.
24931193
Status
Active
Number of Employees
0
Total Paid-in Capital
568,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Introduction
Founded in 2015, Apollo Medical Optics (AMO) is a medical technology company developing medical imaging system based on the revolutionary technology, Optical Coherence Tomography (OCT).

AMO’s core technology was developed at National Taiwan University (NTU), when AMO’s researchers first began investigating medical optics. Our unique crystal fiber technology brings the OCT to a new era, which gives AMO’s product a competitive advantage, with cellular level resolution and a faster scanning speed.



More ↓

Similar Companies

CADUCEUS BIOTECHNOLOGY INC.

1. SpinScan Microarray Scanner
2. Digital Micro Beads Fluorescence Reader
3. Digital ELISA Reader
4. Real-time LAMP Tester
5. Microarray Wafer Scanner
6. Medical Imaging Software Development
7. Microarray Services

JelloX Biotech Inc.

JelloX has launched the first product “JX ACE 3D Pathology Imaging Service” to provide customers high resolution pathology images. Special advantages including high accuracy, convenience and efficiency make it a rapid and economic commercialized 3D pathology product most suitable for current pathology diagnosis workflow. In addition to nuclei, membrane, and antibody staining signals, our product can detect 3D pathology signatures invisible by conventional 2D methodology. We have discovered multiple novel 3D morphology and biomarker features with strong concordance to clinical treatment outcome, along with AI algorithm and precise quantitative analysis new cancer diagnosis models have been established. Our innovative discovery and clinical validation have been published in scientific journals and international conferences, demonstrating superiority of 3D pathology diagnosis. Moreover, our MetaLite 3D pathology analysis software and high speed scanner will be launched to complete an integrated “3D digital pathology imaging and AI auxiliary analysis platform” in order to penetrate international business opportunity of precision diagnosis and AI medicine.